Adriana Cristina Camargos de Rezende
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Adriana Cristina Camargos de Rezende has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Soares Bifano
Postgraduate Program in Infectious Diseases and Tropical Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte 30130-100, Minas Gerais, Brazil
2 shared publications - Beatriz Vieira Melo
Infectious Diseases Service, Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte 30130-100, Minas Gerais, Brazil
2 shared publications - Felipe Torreão Corrêa Thiemann
Infectious Diseases Service, Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte 30130-100, Minas Gerais, Brazil
2 shared publications - Frederico Figueiredo Amâncio
Infectious Diseases Service, Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte 30130-100, Minas Gerais, Brazil
2 shared publications - Giulia Bravim Gonçalves
Infectious Diseases Service, Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte 30130-100, Minas Gerais, Brazil
2 shared publications - Helena Duani
Infectious Diseases Service, Department of Internal Medicine, School of Medicine, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil
2 shared publications
Latest Publications
- Open Access
- 11 September 2026
- Published by MDPI AG in Journal of Fungi
- Vol. 12 (9) , 685
Localized Cutaneous Versus Deep Sporotrichosis at Hospital das Clínicas, UFMG, Belo Horizonte, Brazil: A Cohort of 213 Culture-Confirmed Cases, 2011 to 2026
Background: The zoonotic epidemic of sporotrichosis caused by Sporothrix brasiliensis has expanded throughout Brazil and other countries, with a rise in deep forms of disease. Detailed comparative data on the presentation, treatment and outcomes of cutaneous and deep disease are needed to follow how Brazilian cohorts are evolving. Methods: The study involves a retrospective observational cohort of patients with sporotrichosis treated at a quaternary university hospital in Belo Horizonte between 2011 and 2026, restricted to culture-positive cases. Localized cutaneous disease was compared with deep infection using logistic regression adjusted for age and sex. Results: Of 313 patients, 213 had a positive culture. The median age was 41 years, and 54.0% were women. Lymphocutaneous disease predominated (54.0%), and contact with cats was reported by 53.1%. The median treatment duration was 150 days. Among the 101 patients with a defined outcome, 97 were cured (96.0%), with no documented treatment failure. All four sporotrichosis-related deaths occurred in the deep infection group, which was independently associated with comorbidity (OR 9.69; 95% CI 2.52 to 37.23) and an immunosuppressive condition (OR 6.61; 95% CI 1.89 to 23.09). Conclusions: Localized cutaneous sporotrichosis was cured in nearly all the patients with documented follow-up, whereas mortality was confined to deep infection associated with comorbidities and immunosuppression.
- 11 September 2026
- Published by MDPI AG in Journal of Fungi
- Vol. 12 (9) , 685
Open AccessLocalized Cutaneous Versus Deep Sporotrichosis at Hospital das Clínicas, UFMG, Belo Horizonte, Brazil: A Cohort of 213 Culture-Confirmed Cases, 2011 to 2026
Background: The zoonotic epidemic of sporotrichosis caused by Sporothrix brasiliensis has expanded throughout Brazil and other countries, with a rise in deep forms of disease. Detailed comparative data on the presentation, treatment and outcomes of cutaneous and deep disease are needed to follow how Brazilian cohorts are evolving. Methods: The study involves a retrospective observational cohort of patients with sporotrichosis treated at a quaternary university hospital in Belo Horizonte between 2011 and 2026, restricted to culture-positive cases. Localized cutaneous disease was compared with deep infection using logistic regression adjusted for age and sex. Results: Of 313 patients, 213 had a positive culture. The median age was 41 years, and 54.0% were women. Lymphocutaneous disease predominated (54.0%), and contact with cats was reported by 53.1%. The median treatment duration was 150 days. Among the 101 patients with a defined outcome, 97 were cured (96.0%), with no documented treatment failure. All four sporotrichosis-related deaths occurred in the deep infection group, which was independently associated with comorbidity (OR 9.69; 95% CI 2.52 to 37.23) and an immunosuppressive condition (OR 6.61; 95% CI 1.89 to 23.09). Conclusions: Localized cutaneous sporotrichosis was cured in nearly all the patients with documented follow-up, whereas mortality was confined to deep infection associated with comorbidities and immunosuppression.
- Open Access
- 13 August 2026
- Published by MDPI AG in Preprints.org
Localized Cutaneous Versus Deep Sporotrichosis at Hospital das Clínicas, UFMG, Belo Horizonte, Brazil: A Cohort of 213 Culture-Confirmed Cases, 2011 to 2026
Background: The zoonotic epidemic of sporotrichosis caused by Sporothrix brasiliensis has expanded throughout Brazil and other countries, with a rise in deep forms of disease. Detailed comparative data on presentation, treatment and outcome of cutaneous and deep disease are needed to follow how Brazilian cohorts are evolving. Methods: Retrospective observational cohort of patients with sporotrichosis treated at a quaternary university hospital in Belo Horizonte between 2011 and 2026, restricted to culture-positive cases. Localized cutaneous disease was compared with deep infection using logistic regression adjusted for age and sex. Results: Of 313 patients, 213 had a positive culture. Median age was 41 years and 54.0% were women. Lymphocutaneous disease predominated (54.0%) and contact with cats was reported by 53.1%. Median treatment duration was 150 days. Among the 101 patients with a defined outcome, 97 were cured (96.0%), with no documented treatment failure. All four sporotrichosis-related deaths occurred in the deep infection group, which was independently associated with comorbidity (OR 9.69; 95% CI 2.52 to 37.23) and with an immunosuppressive condition (OR 6.61; 95% CI 1.89 to 23.09). Conclusions: Localized cutaneous sporotrichosis was cured in nearly all patients with documented follow-up, whereas mortality was confined to deep infection associated with comorbidity and immunosuppression.
- 13 August 2026
- Published by MDPI AG in Preprints.org
Open AccessLocalized Cutaneous Versus Deep Sporotrichosis at Hospital das Clínicas, UFMG, Belo Horizonte, Brazil: A Cohort of 213 Culture-Confirmed Cases, 2011 to 2026
Background: The zoonotic epidemic of sporotrichosis caused by Sporothrix brasiliensis has expanded throughout Brazil and other countries, with a rise in deep forms of disease. Detailed comparative data on presentation, treatment and outcome of cutaneous and deep disease are needed to follow how Brazilian cohorts are evolving. Methods: Retrospective observational cohort of patients with sporotrichosis treated at a quaternary university hospital in Belo Horizonte between 2011 and 2026, restricted to culture-positive cases. Localized cutaneous disease was compared with deep infection using logistic regression adjusted for age and sex. Results: Of 313 patients, 213 had a positive culture. Median age was 41 years and 54.0% were women. Lymphocutaneous disease predominated (54.0%) and contact with cats was reported by 53.1%. Median treatment duration was 150 days. Among the 101 patients with a defined outcome, 97 were cured (96.0%), with no documented treatment failure. All four sporotrichosis-related deaths occurred in the deep infection group, which was independently associated with comorbidity (OR 9.69; 95% CI 2.52 to 37.23) and with an immunosuppressive condition (OR 6.61; 95% CI 1.89 to 23.09). Conclusions: Localized cutaneous sporotrichosis was cured in nearly all patients with documented follow-up, whereas mortality was confined to deep infection associated with comorbidity and immunosuppression.